This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, D. R. Articles by Breslow, M. J. Search for Related Content PubMed PubMed Citation Articles by Brown, D. R. Articles by Breslow, M. J.

Weight Loss Is Not Associated with Hyperleptinemia in Humans with Pancreatic Cancer

Department of Anesthesiology and Critical Care, Mayo Clinic (D.R.B.), Rochester, Minnesota 55905; Department of Anesthesiology, Johns Hopkins University School of Medicine (D.E.B.), Baltimore, Maryland 21287; and ICUSA, Inc. (M.J.B.), Baltimore, Maryland 21224

Address all correspondence and requests for reprints to: Daniel R. Brown, M.D., Ph.D., Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: brown.daniel{at}mayo.edu

Pathological weight loss is a feature of many diseases and contributes to mortality and morbidity. Although cytokines have been implicated in some models of pathological weight loss, little is known about cellular mechanisms responsible for cachexia in patients with cancer. Leptin is a fat cell product that acts centrally to reduce appetite and decrease metabolism. Leptin synthesis is stimulated by cytokines, and circulating levels of cytokines are elevated in some cancer patients. We hypothesized that cytokine-induced hyperleptinemia contributes to pathological weight loss in patients with pancreatic cancer. To evaluate this hypothesis, fasting serum leptin concentrations were measured in 64 patients undergoing surgery for pancreatic cancer. Preoperative interviews were used to assess body weight and appetite history. Thirty of 64 pancreatic cancer patients had cachexia (weight loss of >10% over the 6 months before surgery). Self-reported loss of appetite was associated with the presence of cachexia. Leptin concentrations, when corrected for body mass index, were lower than levels reported in healthy humans. Six patients had leptin levels more than 2 times those predicted by body mass index. There was no association between patients with increased leptin concentration and weight loss or anorexia. We conclude that a reduced appetite contributes to weight loss in patients with pancreatic cancer. High plasma leptin levels, however, do not appear to contribute to cachexia in these patients.

This article has been cited by other articles:

				E. R. Ropelle, J. R. Pauli, K. G. Zecchin, M. Ueno, C. T. de Souza, J. Morari, M. C. Faria, L. A. Velloso, M. J. A. Saad, and J. B. C. Carvalheira A Central Role for Neuronal Adenosine 5'-Monophosphate-Activated Protein Kinase in Cancer-Induced Anorexia Endocrinology, November 1, 2007; 148(11): 5220 - 5229. [Abstract] [Full Text] [PDF]

				Q. Huang, X. Zhang, Z.-W. Jiang, B.-Z. Liu, N. Li, and J.-S. Li Hypoleptinemia in Gastric Cancer Patients: Relation to Body Fat Mass, Insulin, and Growth Hormone JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4): 229 - 235. [Abstract] [Full Text] [PDF]

				D Basso, C Millino, E Greco, C Romualdi, P Fogar, A Valerio, M Bellin, C-F Zambon, F Navaglia, N Dussini, et al. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes Gut, August 1, 2004; 53(8): 1159 - 1166. [Abstract] [Full Text] [PDF]

				F. Santolaria, A. Perez-Cejas, M.-R. Aleman, E. Gonzalez-Reimers, A. Milena, M.-J. De La Vega, A. Martinez-Riera, and M.-A. Gomez-Rodriguez LOW SERUM LEPTIN LEVELS AND MALNUTRITION IN CHRONIC ALCOHOL MISUSERS HOSPITALIZED BY SOMATIC COMPLICATIONS Alcohol Alcohol., January 1, 2003; 38(1): 60 - 66. [Abstract] [Full Text] [PDF]